Abstract
Interleukin‐15 (IL‐15) is a pro‐inflammatory cytokine known as a general inhibitor of apoptosis, which possesses potential therapeutic properties. Although IL‐15 was previously found to be a human neutrophil agonist, its mode of action remains unknown. Herein, we were interested in elucidating the mechanisms by which it delays neutrophil apoptosis. IL‐15 was found to induce tyrosine phosphorylation events and to prevent loss of the anti‐apoptotic Mcl‐1 protein expression. Using different signal transduction inhibitors, we found that Janus kinase (Jak)‐2, Jak‐3, p38 mitogen‐activated protein kinase (MAPK) and extracellular signal‐regulated kinase (ERK), but not G proteins, are involved in IL‐15‐induced suppression of apoptosis. Furthermore, we found that IL‐15 activates Jak‐2, p38 MAPK and ERK‐1/2, but, unlike granulocyte macrophage‐colony‐stimulating factor (GM‐CSF), it does not activate signal transducer and activator of transcription (STAT)‐5a/b. We conclude that IL‐15 delays neutrophil apoptosis via several pathways, and that Mcl‐1 and several kinases contribute to this. We also conclude that, unlike GM‐CSF, IL‐15 does not activate the Jak‐2/STAT‐5 pathway found to be important in neutrophil signaling.

This publication has 52 references indexed in Scilit: